GlassScriptPhysician profile
Abraham E Rodriguez
NPI 1891141495
$2,510.29
in general payments reported to CMS, 2019-2025
22 companies · $1,027 in 2025
The $1,027 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.08 · 2022: $613 · 2023: $213 · 2024: $611 · 2025: $1,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,851.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm Sonosite, INC. | $447.52 | 2022 | |
| Glaxosmithkline, LLC. | $281.39 | 2024-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Regeneron Healthcare Solutions, INC. | $268.60 | 2024-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $256.67 | 2023-2025 | Breztri, Airsupra, Tezspire |
| Genzyme Corporation | $170.87 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.23 | 2022-2025 | Ofev, Jascayd |
| United Therapeutics Corporation | $139.49 | 2023-2025 | Tyvaso, Tyvaso |
| Janssen Pharmaceuticals, INC | $123.81 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $103.42 | 2024-2025 | Glassia |
| Viatris Specialty LLC | $88.88 | 2025 | Yupelri |
| Ani Pharmaceuticals, INC. | $70.06 | 2024-2025 | Purified Cortrophin Gel |
| Pulmonx Corporation | $67.91 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Mallinckrodt Hospital Products INC. | $59.71 | 2024-2025 | Acthar |
| Shionogi INC | $52.15 | 2023 | Fetroja |
| Fisher Scientific Company L.L.C. | $46.08 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $44.53 | 2024 | Yupelri |
| Baxter Healthcare | $37.12 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Electromed, INC. | $31.71 | 2024 | Smartvest |
| Abbvie INC. | $27.41 | 2025 | |
| Tactile Systems Technology INC | $24.67 | 2025 | Flexitouch Plus, Nimbl |
| Merck Sharp & Dohme LLC | $20.82 | 2022 | |
| 3b Medical, INC. | $6.24 | 2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abraham Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.